Nu Skin beats by $0.08, beats on revs; guides Q4 EPS below consensus, revs below consensus:
- Reports Q3 (Sep) adj. earnings of $0.91 per share, $0.08 better than the Capital IQ Consensus of $0.83; revenues rose 5.7% year/year to $604 mln vs the $585.91 mln Capital IQ Consensus. Vhina sales +20%, North ASia +14%, S ASia/Pacific -36%, Americas +3%, EMEA +5%.
- Co issues downside guidance for Q4, sees EPS of $0.77-0.81 vs. $0.83 Capital IQ Consensus Estimate; sees Q4 revs of $550-570 mln vs. $591.18 mln Capital IQ Consensus Estimate.
- "We look forward to discussing our 2017 plans with shareholders at our annual investor day to be held on December 7, 2016 in New York."
No comments:
Post a Comment